Elbow Replacement Market Major Key Players (BIOMET, DE PUY SYNTHES, LIMA CORPORATE, OTTOBOCK HEALTHCARE, STRYKER CORPORATION, WRIGHT MEDICAL GROUP, ZIMMER HOLDINGS)

Elbow Replacement Market Highlights
The global elbow replacement market is expected to register a good CAGR during the forecast period, 2018 to 2023. In elbow replacement, the physician replaces the elbow with an artificial joint made from two implants that attaches to the bones in the arm. A metal and plastic hinge joins the implants together. The damaged parts of the elbow are replaced with artificial elbow devices through a surgery which is known as Elbow Replacement or Elbow Arthroplasty. This procedure is suggested for elbow rheumatoid arthritis patients. Elbow replacement can also be extended to cases, such as distal humerus fractures, distal humerus nonunions, and other elbow injuries.

Get your sample report now @ https://marketprognosis.com/sample-request/16909
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Key Developments in the Market:
February 2018 u2013 Stryker has completed the acquisition of Entellus Medical

Major Players:
BIOMET INC., DE PUY SYNTHES, LIMA CORPORATE, OTTOBOCK HEALTHCARE, STRYKER CORPORATION, WRIGHT MEDICAL GROUP, ZIMMER HOLDINGS INC., among others.

Growing Number of Elbow Arthritis
The market is mostly driven by the increasing number of rheumatoid arthritis patients. It was estimated that around 30-40% of the total rheumatoid arthritis (RA) patients suffer from elbow joint problems. This increasing disease burden of the RA is driving the elbow replacement market.
An increase in the ageing population and lifestyles, coupled with the rise in prevalence of orthopedic diseases, are expected to drive the elbow replacement market. The other factors, such as growing number of elbow injuries and sedentary lifestyles are driving the elbow replacement market.

Get Discount on this report @ https://marketprognosis.com/discount-request/16909
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Availability of Alternatives
Around 90% of patients are suffering from elbow diseases who undergo treatment through medication and around 15-20% of patients are treated through these surgeries. Around 5-10% of the patients are recommended for arthroplasty. The usage of the traditional methods is still predominant and preferred over the new technology. This preference for alternative methods can hamper the growth of the elbow replacement market. Also, due to the high cost of these procedures, this acts as the restraining cause for the elbow replacement market. The other factor, such as cost of the procedure is also hindering the growth of the market.

US Lead the Market in North America Region
The US elbow replacement market holds the largest market share in 2017 in North America region due to the presence of high quality healthcare system and presence of more number of arthritis patients. In the APAC sector, China and India have been identified as potential emerging markets.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/16909
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.